Long-term efficacy and safety of romiplostim in refractory aplastic anemia: follow-up of a phase 2/3 study.
作者信息
Mitani Kinuko, Lee Jong Wook, Jang Jun Ho, Tomiyama Yoshiaki, Miyazaki Koji, Nagafuji Koji, Usuki Kensuke, Uoshima Nobuhiko, Fujisaki Tomoaki, Kosugi Hiroshi, Matsumura Itaru, Sasaki Ko, Kizaki Masahiro, Sawa Masashi, Hidaka Michihiro, Kobayashi Naoki, Ichikawa Satoshi, Yonemura Yuji, Murotani Kenta, Shimizu Mami, Matsuda Akira, Ozawa Keiya, Nakao Shinji
机构信息
Department of Hematology and Oncology, Dokkyo Medical University, Tochigi, Japan.
Division of Hematology, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, Republic of Korea.
出版信息
Blood Adv. 2024 Mar 26;8(6):1415-1419. doi: 10.1182/bloodadvances.2023010959.
Abstract
摘要
相似文献
1
Long-term efficacy and safety of romiplostim in refractory aplastic anemia: follow-up of a phase 2/3 study.
Blood Adv. 2024 Mar 26;8(6):1415-1419. doi: 10.1182/bloodadvances.2023010959.
2
Nationwide survey in France on the use of romiplostim in patients with refractory severe aplastic anemia.
Bone Marrow Transplant. 2019 Jul;54(7):1161-1163. doi: 10.1038/s41409-019-0452-1. Epub 2019 Jan 22.
3
Romiplostim in patients with refractory aplastic anaemia previously treated with immunosuppressive therapy: a dose-finding and long-term treatment phase 2 trial.
Lancet Haematol. 2019 Nov;6(11):e562-e572. doi: 10.1016/S2352-3026(19)30153-X. Epub 2019 Aug 29.
4
Efficacy and safety of romiplostim in refractory aplastic anaemia: a Phase II/III, multicentre, open-label study.
Br J Haematol. 2021 Jan;192(1):190-199. doi: 10.1111/bjh.17190. Epub 2020 Nov 5.
5
Romiplostim for Treatment of Children and Young Adults With Severe Aplastic Anemia and Myelodysplastic Syndrome.
J Pediatr Hematol Oncol. 2024 Jul 1;46(5):252-261. doi: 10.1097/MPH.0000000000002891. Epub 2024 May 24.
6
Romiplostim is effective for eltrombopag-refractory aplastic anemia: results of a retrospective study.
Int J Hematol. 2020 Dec;112(6):787-794. doi: 10.1007/s12185-020-02971-1. Epub 2020 Sep 2.
7
[Efficacy and safety of romiplostim in aplastic anemia refractory or intolerant to immunosuppressive therapy with eltrombopag].
Rinsho Ketsueki. 2025;66(2):92-99. doi: 10.11406/rinketsu.66.92.
8
Romiplostim in aplastic anaemia - another tool in the armamentarium.
Br J Haematol. 2021 Jan;192(1):15-16. doi: 10.1111/bjh.17189. Epub 2020 Nov 5.
9
Increased requirement for platelet transfusions concurrent with enhanced bleeding during romiplostim treatment in a patient with thrombocytopenia due to bone marrow failure.
Ann Hematol. 2011 Nov;90(11):1357-9. doi: 10.1007/s00277-011-1180-9. Epub 2011 Feb 16.
10
High-dose romiplostim accelerates hematologic recovery in patients with aplastic anemia refractory to eltrombopag.
Leukemia. 2021 Mar;35(3):906-909. doi: 10.1038/s41375-020-0950-6. Epub 2020 Jul 3.
引用本文的文献
1
Effective treatment of refractory aplastic anemia with romiplostim after failure of multiple thrombopoietin receptor agonists: a single-center retrospective study.
Ann Med. 2025 Dec;57(1):2514791. doi: 10.1080/07853890.2025.2514791. Epub 2025 Jun 19.
2
Elderly Patients With Aplastic Anemia: Treatment Patterns and Outcomes in the Real World.
Am J Hematol. 2025 Apr;100(4):584-591. doi: 10.1002/ajh.27611. Epub 2025 Jan 29.
3
Modified Delphi panel consensus recommendations for management of severe aplastic anemia.
Blood Adv. 2024 Aug 13;8(15):3946-3960. doi: 10.1182/bloodadvances.2023011642.
本文引用的文献
1
Efficacy and safety of romiplostim in refractory aplastic anaemia: a Phase II/III, multicentre, open-label study.
Br J Haematol. 2021 Jan;192(1):190-199. doi: 10.1111/bjh.17190. Epub 2020 Nov 5.
2
Romiplostim in patients with refractory aplastic anaemia previously treated with immunosuppressive therapy: a dose-finding and long-term treatment phase 2 trial.
Lancet Haematol. 2019 Nov;6(11):e562-e572. doi: 10.1016/S2352-3026(19)30153-X. Epub 2019 Aug 29.
3
Treatment optimization and genomic outcomes in refractory severe aplastic anemia treated with eltrombopag.
Blood. 2019 Jun 13;133(24):2575-2585. doi: 10.1182/blood.2019000478. Epub 2019 Apr 16.
4
Romiplostim.
Drugs. 2009;69(3):307-17. doi: 10.2165/00003495-200969030-00006.
Zotero 插件